Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1131-1132

  Kupin, W ^a   Venkat, K K ^a   Goggins, M ^a   Douzdjian, V ^a   Escobar III, F ^a   Mozes, M ^a   Abouljoud, M ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ATHEROSCLEROSIS; AVASCULAR NECROSIS; CADAVER KIDNEY; CATARACT; CHRONOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

AZATHIOPRINE; CADAVER; CHOLESTEROL; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; STEROIDS; TISSUE DONORS;

EID: 0032986243     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01933-2     Document Type: Conference Paper

References (7)

1. Fryer J.P., Granger D.K. Clin Transplant. 8:1994;224.
2. Ratcliffe P.J., Dudley C.R., Higgins R.M., et al. Lancet. 348:1996;643.
3. Tarantino A., Montagnimo G., Ponticelli C. Drug Saf. 13:1995;145.
4. Transplantation. 61:1996;1029.
5. Grinyo J.M., Vernet S., Seron D., et al. Transplantation. 63:1997;1688.
6. Hricik D.E., Schulak J.A. Kidney Int. 44:1993;S26.
7. Hricik D., O'Toole M.A., Schulak J.A., et al. J Am Soc Nephrol. 4:1993;1300.